Psychology
Treatment
77%
Attention Deficit
77%
Schizophrenia
50%
Depression
49%
Groups
47%
Interviews
36%
Methylphenidate
32%
Behavior
30%
Assessment
29%
Bipolar Disorder
24%
Attention
23%
Dopamine
23%
Children
23%
Anxiety
19%
Comorbidity
18%
Dehydroepiandrosterone
18%
Psychiatric Disorder
18%
Rating Scale
17%
I-Disorder
16%
Cognition
15%
Health
14%
Meta-Analysis
14%
Depression Scale
14%
Major Depression
13%
Gender Difference
13%
Adolescents
13%
Patient with Attention Deficit Hyperactivity Disorder
13%
Quality of Life
13%
Mood
13%
Psychotic Disorder
12%
Alcohol
12%
Cognitive Decline
11%
Mood Disorder
11%
Clinical Interview
10%
Schizoaffective Disorder
9%
Prevention Program
9%
Cognitive Behavioral Therapy
9%
Questionnaires
8%
Reliability
8%
Depression
7%
Validity
7%
Obesity
7%
Cognitive Performance
7%
Reaction Time
7%
Kidney Disease
7%
Processing Speed
7%
Psychometrics
7%
Teachers
6%
Cortisol
6%
Hazard Ratio
6%
Medicine and Dentistry
Patient
100%
Therapeutic Procedure
54%
Inpatient
37%
Symptom
35%
Attention Deficit Disorder
31%
Methamphetamine
31%
Association
30%
Psychosis
29%
Bipolar Disorder
29%
Chemotherapeutic Agent
19%
Drug
19%
Major Depressive Episode
19%
Diagnosis
18%
Chronic Kidney Disease
18%
Ketamine
18%
Hemodialysis
18%
Anxiety
17%
Follow up
15%
Drug Use
15%
Male
14%
Cognition
14%
Age
14%
Meta-Analysis
14%
Psychoactive Drug
14%
Methylphenidate
14%
Analysis
14%
Psychosis
13%
Illicit Drug
13%
Disease
13%
Gene
12%
Hospital
11%
Hospital Anxiety and Depression Scale
11%
Odds Ratio
11%
Infection
10%
Bipolar I Disorder
10%
Mental Health
10%
Mood Stabilizer
10%
Screening
10%
Family
10%
Quality of Life
10%
Lithium
9%
Anxiety Disorder
9%
Typical Antipsychotic
9%
Patient with Attention Deficit Hyperactivity Disorder
9%
Young Adult
9%
Sex Difference
9%
Adolescent
9%
Olanzapine
9%
Mood Disorder
9%
Systematic Review
9%
Neuroscience
Attention Deficit Hyperactivity Disorder
72%
Methamphetamine
48%
Gene
46%
Depression
43%
Bipolar Disorder
43%
Polymorphism
42%
Ketamine
37%
Methylphenidate
27%
Dementia Praecox
27%
Aripiprazole
22%
Psychosis
21%
Bipolar I Disorder
20%
Major Depressive Disorder
18%
Brain-Derived Neurotrophic Factor
18%
Subjective Cognitive Decline
18%
Haplotype
17%
Olanzapine
16%
Attention
15%
Cognition
15%
Antipsychotic
14%
Serotonin Transporter
14%
Anxiety
13%
Behavior (Neuroscience)
12%
Dopamine
12%
Mood Stabilizer
11%
Lithium
11%
Synapsin I
11%
Cognitive Disorders
10%
Variable Number Tandem Repeat
10%
Sleep
9%
Genotype
9%
DNA Polymorphism
9%
Dehydroepiandrosterone Sulfate
9%
Dehydroepiandrosterone
9%
Dopamine Transporter
9%
Schizoaffective Disorder
9%
Methamphetamine-Induced Psychosis
9%
Test of Variables of Attention
8%
Promoter Region
8%
5-HTTLPR
7%
Untranslated Region
7%
Physical Dependence
7%
Glutamic Acid
6%
Primary Insomnia
6%
Brain
6%
Single-Nucleotide Polymorphism
6%
Psychiatry
6%
Schizophrenia Spectrum Disorder
6%
Hyperactivity
6%
Comorbidity
5%